Mega Genomics Limited

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 2359.HK has a market cap of 186.75B. Regarding current trading prices, 6667.HK is priced at $7.20, while 2359.HK trades at $63.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 2359.HK's P/E ratio is 15.05. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 2359.HK's ROE of +0.19%. Regarding short-term risk, 6667.HK is less volatile compared to 2359.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 2268.HK has a market cap of 45.88B. Regarding current trading prices, 6667.HK is priced at $7.20, while 2268.HK trades at $38.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 2268.HK's P/E ratio is 42.39. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 2268.HK's ROE of +0.09%. Regarding short-term risk, 6667.HK is less volatile compared to 2268.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 3347.HK has a market cap of 34.35B. Regarding current trading prices, 6667.HK is priced at $7.20, while 3347.HK trades at $25.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 3347.HK's P/E ratio is 60.36. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 3347.HK's ROE of +0.02%. Regarding short-term risk, 6667.HK is less volatile compared to 3347.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 6127.HK has a market cap of 11.92B. Regarding current trading prices, 6667.HK is priced at $7.20, while 6127.HK trades at $9.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 6127.HK's P/E ratio is 17.64. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 6127.HK's ROE of +0.05%. Regarding short-term risk, 6667.HK is less volatile compared to 6127.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 2325.HK has a market cap of 2.05B. Regarding current trading prices, 6667.HK is priced at $7.20, while 2325.HK trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 2325.HK's P/E ratio is -2.43. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 2325.HK's ROE of -0.11%. Regarding short-term risk, 6667.HK is less volatile compared to 2325.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 8037.HK has a market cap of 683.01M. Regarding current trading prices, 6667.HK is priced at $7.20, while 8037.HK trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 8037.HK's P/E ratio is -3.33. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 8037.HK's ROE of -0.60%. Regarding short-term risk, 6667.HK is less volatile compared to 8037.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 8225.HK has a market cap of 159.26M. Regarding current trading prices, 6667.HK is priced at $7.20, while 8225.HK trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 8225.HK's P/E ratio is 8.00. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 8225.HK's ROE of -0.18%. Regarding short-term risk, 6667.HK is less volatile compared to 8225.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.

6667.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6667.HK stands at 1.61B. In comparison, 0928.HK has a market cap of 146.18M. Regarding current trading prices, 6667.HK is priced at $7.20, while 0928.HK trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6667.HK currently has a P/E ratio of 42.35, whereas 0928.HK's P/E ratio is 7.90. In terms of profitability, 6667.HK's ROE is +0.05%, compared to 0928.HK's ROE of +0.05%. Regarding short-term risk, 6667.HK is less volatile compared to 0928.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6667.HK.